Breaking Barriers First Engineered Cell Therapy for Solid Tumors Earns FDA Accelerated Approval
FDA Grants Accelerated Approval for TECELRA: Pioneering Engineered Cell Therapy for Solid Tumors CSIMarket.com Staff Writer Adaptimmune Therapeutics plc, a biopharmaceutical company focused on developing cell therapies...
Aug 2, 2024
• Biotechnology & Pharmaceuticals Industry
Business Update
NASDAQ
